Zapping away cancer's lingering side effects: NESA device tested on survivors

NCT ID NCT06230679

Completed Symptom relief Sponsor: Aníbal Báez Suárez Source: ClinicalTrials.gov ↗

First seen Jun 24, 2026 · Last updated Jun 27, 2026 · Updated 2 times

Summary

This completed study tested a non-invasive device called NESA that gently stimulates nerves to help cancer survivors with sleep problems, fatigue, and muscle pain. Forty survivors who had finished cancer treatment at least five years ago took part. The goal was to see if the device could improve their quality of life by easing these common late effects.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: NESA non-invasive neurostimulation device
What this could lead to: If it works, this could offer a drug-free option to ease common late effects of cancer treatment, improving quality of life for survivors.
What could go wrong: This is a small, completed trial with only 40 participants. Results may not apply to all survivors, and the placebo effect could play a role.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for CANCER SURVIVORS are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

neoplasm

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

CANCER SURVIVORS

Contacts and locations

Locations

Gutmotion

Santa Maria del Camí, Balearic, 07320, Spain

More trials for these conditions

Other studies related to the condition(s) this trial covers.